Article info
PDFClinical ethics
Paper
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism
- Correspondence to Dr Gary P Wormser, New York Medical College, Division of Infectious Diseases, Munger Pavilion Room 245, Valhalla, NY 10595, USA; gary_wormser{at}nymc.edu
Citation
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism
Publication history
- Received August 28, 2009
- Revised September 6, 2010
- Accepted September 17, 2010
- First published November 21, 2010.
Online issue publication
January 20, 2011
Article Versions
- Previous version (21 November 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process
- Lyme disease in the United Kingdom
- Unique expression of chronic Lyme disease and Jarisch-Herxheimer reaction to doxycycline therapy in a young adult
- Lyme borreliosis: diagnosis and management
- Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study
- Lyme wars
- Lyme disease: summary of NICE guidance
- Lyme disease following a dog bite – was there a tick?
- Lyme disease: diagnosis and management
- Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable